Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (NASDAQ:OACC) — Stock Price

$10.74 USD
▲ 0.00% today

Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (NASDAQ:OACC) is currently trading at $10.74 USD, up 0.00% today. Over the past 52 weeks, shares have ranged between $10.30 and $10.75. This page tracks Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share's live share price on the NASDAQ exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Oaktree Acquisition Corp. III Life Scien (OACC) market capitalisation.

Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (OACC) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share's daily closing share price and trading volume on the NASDAQ exchange over the past year, giving a clear view of recent price momentum and liquidity.

Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share Income Statement — Revenue, Profit & Earnings by Year

Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 2025
Total Revenue $0.00
Cost of Revenue
Gross Profit
Research & Development
SG&A $1.20 Million
Total Operating Expenses $1.20 Million
Operating Income $-1.20 Million
EBITDA $-1.20 Million
EBIT
Interest Expense
Income Before Tax $7.29 Million
Income Tax Expense
Net Income $7.29 Million

Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024
Total Assets $203.11 Million $195.25 Million
Total Current Assets $1.55 Million $1.56 Million
Cash & Equivalents
Short-term Investments
Net Receivables
Inventory
Property, Plant & Equipment
Goodwill
Total Liabilities $8.32 Million $7.75 Million
Total Current Liabilities $1.30 Million $727.32K
Long-term Debt
Net Debt $-1.42 Million $-1.35 Million
Total Stockholder Equity $194.79 Million $187.50 Million
Retained Earnings $-6.77 Million $-6.08 Million

Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024
Operating Cash Flow $-422.08K $-89.69K
Capital Expenditures $0.00 $3.00
Free Cash Flow $-422.08K $-179.00
Investing Cash Flow $500.00K $-191.99 Million
Financing Cash Flow $0.00 $193.44 Million
Dividends Paid
Stock-Based Compensation
Depreciation
Change in Cash $77.92K $1.36 Million

Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share Earnings History — EPS Actual vs. Analyst Estimates

Track Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Mar 31, 2026 0.06
Dec 31, 2025 0.07
Nov 13, 2025 0.08
Aug 12, 2025 0.08
May 14, 2025 0.07
Dec 31, 2024 0.06
Oct 04, 2024 -0.01 0.00